Amyotrophic Lateral Sclerosis / / edited by Muralidhar L. Hegde.

A flurry of recent research on the role of the RNA/DNA-binding proteins TDP-43 and FUS as well as a dozen other factors (e.g., C9ORF72 and profilin) has led to a new paradigm in our understanding of the pathobiology of the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). How these factors...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London, United Kingdom : : IntechOpen,, 2020.
Year of Publication:2020
Language:English
Physical Description:1 online resource (160 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603136904498
ctrlnum (CKB)5400000000040557
(NjHacI)995400000000040557
(EXLCZ)995400000000040557
collection bib_alma
record_format marc
spelling Amyotrophic Lateral Sclerosis / edited by Muralidhar L. Hegde.
Amyotrophic Lateral Sclerosis
London, United Kingdom : IntechOpen, 2020.
1 online resource (160 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
A flurry of recent research on the role of the RNA/DNA-binding proteins TDP-43 and FUS as well as a dozen other factors (e.g., C9ORF72 and profilin) has led to a new paradigm in our understanding of the pathobiology of the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). How these factors trigger neuromuscular dysfunction is critical for developing more effective ALS therapeutics. The 'gain-of-toxicity' or 'loss-of-function' of these etiological factors is a key question. Recent studies on the imbalance in genome damage versus repair have opened avenues for potential DNA repair-based therapeutics. This book highlights emerging science in the area of ALS and discusses key approaches and mechanisms essential for developing a cure for ALS.
Amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis Treatment.
1-83880-582-6
Hegde, Muralidhar L., editor.
language English
format eBook
author2 Hegde, Muralidhar L.,
author_facet Hegde, Muralidhar L.,
author2_variant m l h ml mlh
author2_role TeilnehmendeR
title Amyotrophic Lateral Sclerosis /
spellingShingle Amyotrophic Lateral Sclerosis /
title_full Amyotrophic Lateral Sclerosis / edited by Muralidhar L. Hegde.
title_fullStr Amyotrophic Lateral Sclerosis / edited by Muralidhar L. Hegde.
title_full_unstemmed Amyotrophic Lateral Sclerosis / edited by Muralidhar L. Hegde.
title_auth Amyotrophic Lateral Sclerosis /
title_alt Amyotrophic Lateral Sclerosis
title_new Amyotrophic Lateral Sclerosis /
title_sort amyotrophic lateral sclerosis /
publisher IntechOpen,
publishDate 2020
physical 1 online resource (160 pages) : illustrations
isbn 1-83880-582-6
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC406
callnumber-sort RC 3406 A24 A496 42020
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.83
dewey-sort 3616.83
dewey-raw 616.83
dewey-search 616.83
work_keys_str_mv AT hegdemuralidharl amyotrophiclateralsclerosis
status_str n
ids_txt_mv (CKB)5400000000040557
(NjHacI)995400000000040557
(EXLCZ)995400000000040557
carrierType_str_mv cr
is_hierarchy_title Amyotrophic Lateral Sclerosis /
author2_original_writing_str_mv noLinkedField
_version_ 1796653201802395649
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01727nam a2200289 i 4500</leader><controlfield tag="001">993603136904498</controlfield><controlfield tag="005">20230623121215.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230623s2020 enka o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040557</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000040557</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040557</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC406.A24</subfield><subfield code="b">.A496 2020</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.83</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Amyotrophic Lateral Sclerosis /</subfield><subfield code="c">edited by Muralidhar L. Hegde.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Amyotrophic Lateral Sclerosis </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (160 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A flurry of recent research on the role of the RNA/DNA-binding proteins TDP-43 and FUS as well as a dozen other factors (e.g., C9ORF72 and profilin) has led to a new paradigm in our understanding of the pathobiology of the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). How these factors trigger neuromuscular dysfunction is critical for developing more effective ALS therapeutics. The 'gain-of-toxicity' or 'loss-of-function' of these etiological factors is a key question. Recent studies on the imbalance in genome damage versus repair have opened avenues for potential DNA repair-based therapeutics. This book highlights emerging science in the area of ALS and discusses key approaches and mechanisms essential for developing a cure for ALS.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Amyotrophic lateral sclerosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Amyotrophic lateral sclerosis</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83880-582-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hegde, Muralidhar L.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:25:34 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338036610004498&amp;Force_direct=true</subfield><subfield code="Z">5338036610004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338036610004498</subfield></datafield></record></collection>